NASDAQ:AZTA

Azenta (AZTA) Stock Price, News & Analysis

$54.07
-1.06 (-1.92%)
(As of 05/8/2024 ET)
Today's Range
$54.01
$55.16
50-Day Range
$50.49
$67.30
52-Week Range
$36.01
$69.16
Volume
823,074 shs
Average Volume
431,092 shs
Market Capitalization
$3.01 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$69.60

Azenta MarketRank™ Stock Analysis

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
28.7% Upside
$69.60 Price Target
Short Interest
Bearish
8.32% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.58mentions of Azenta in the last 14 days
Based on 10 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
85.19%
From $0.27 to $0.50 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.93 out of 5 stars

Medical Sector

561st out of 905 stocks

Special Industry Machinery, Not Elsewhere Classified Industry

7th out of 12 stocks

AZTA stock logo

About Azenta Stock (NASDAQ:AZTA)

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

AZTA Stock Price History

AZTA Stock News Headlines

Azenta Announces CEO Succession Plan
The A.I. story nobody is telling you (Read ASAP)
There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...
Azenta, Inc. (NASDAQ:AZTA) Short Interest Up 9.4% in April
The A.I. story nobody is telling you (Read ASAP)
There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...
Azenta is Now Oversold (AZTA)
Decoding 7 Analyst Evaluations For Azenta
In-Depth Examination Of 5 Analyst Recommendations For Azenta
Strong Buy Rating for Azenta, Inc. Amid Growth and Strategic Initiatives
Azenta: Q1 Earnings Insights
Preview: Azenta's Earnings
See More Headlines
Receive AZTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Azenta and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/13/2023
Today
5/08/2024
Next Earnings (Confirmed)
5/08/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Special industry machinery, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:AZTA
Employees
3,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$69.60
High Stock Price Target
$79.00
Low Stock Price Target
$60.00
Potential Upside/Downside
+28.7%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
6 Analysts

Profitability

Net Income
$-14,260,000.00
Pretax Margin
-4.75%

Debt

Sales & Book Value

Annual Sales
$665.07 million
Cash Flow
$1.65 per share
Book Value
$42.10 per share

Miscellaneous

Free Float
54,778,000
Market Cap
$3.01 billion
Optionable
Optionable
Beta
1.51
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Dr. Stephen S. Schwartz (Age 65)
    CEO, President & Director
    Comp: $1.05M
  • Mr. Robin Vacha (Age 48)
    Senior Vice President of Global Operations
    Comp: $533.35k
  • Mr. Jason W. Joseph (Age 53)
    Senior VP, General Counsel & Corporate Secretary
    Comp: $544.13k
  • Mr. Herman Cueto (Age 50)
    Executive VP & CFO
  • Ms. Violetta Hughes (Age 52)
    VP & Chief Accounting Officer
  • Mr. Michael Paulo
    VP and Chief Information & Digital Officer
  • Mr. John E. O'Brien (Age 54)
    Senior Vice President of Corporate Development
  • Ms. Olga Pirogova (Age 50)
    Senior VP & Chief HR Officer
  • Mr. J. Robert Woodward
    Senior Vice President of Global Quality & Regulatory
  • Dr. Ginger Zhou Ph.D. (Age 47)
    Senior VP & GM of Multiomics and Synthesis Solutions

AZTA Stock Analysis - Frequently Asked Questions

Should I buy or sell Azenta stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Azenta in the last twelve months. There are currently 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" AZTA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AZTA, but not buy additional shares or sell existing shares.
View AZTA analyst ratings
or view top-rated stocks.

What is Azenta's stock price target for 2024?

6 brokers have issued twelve-month price targets for Azenta's shares. Their AZTA share price targets range from $60.00 to $79.00. On average, they predict the company's share price to reach $69.60 in the next year. This suggests a possible upside of 28.7% from the stock's current price.
View analysts price targets for AZTA
or view top-rated stocks among Wall Street analysts.

How have AZTA shares performed in 2024?

Azenta's stock was trading at $65.14 on January 1st, 2024. Since then, AZTA shares have decreased by 17.0% and is now trading at $54.07.
View the best growth stocks for 2024 here
.

Are investors shorting Azenta?

Azenta saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 4,550,000 shares, an increase of 9.4% from the March 31st total of 4,160,000 shares. Based on an average daily volume of 445,100 shares, the days-to-cover ratio is presently 10.2 days. Currently, 8.3% of the shares of the stock are short sold.
View Azenta's Short Interest
.

How were Azenta's earnings last quarter?

Azenta, Inc. (NASDAQ:AZTA) posted its earnings results on Monday, November, 13th. The company reported $0.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.12. The company had revenue of $165.95 million for the quarter, compared to analyst estimates of $163.91 million. Azenta had a positive trailing twelve-month return on equity of 0.49% and a negative net margin of 2.92%. The firm's revenue was up 25.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.16 earnings per share.

What guidance has Azenta issued on next quarter's earnings?

Azenta issued an update on its FY24 earnings guidance on Wednesday, May, 8th. The company provided EPS guidance of $0.27-0.37 for the period, compared to the consensus estimate of $0.26. The company issued revenue guidance of $659-671 million, compared to the consensus revenue estimate of $703.74 million.

Who are Azenta's major shareholders?

Azenta's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Conestoga Capital Advisors LLC (2.30%), Allspring Global Investments Holdings LLC (1.90%), Allspring Global Investments Holdings LLC (1.90%), WCM Investment Management LLC (1.43%), Geneva Capital Management LLC (0.92%) and Principal Financial Group Inc. (0.39%). Insiders that own company stock include David C Gray, Jesus Linda De, Kimberly Crowley, Lindon G Robertson and Matthew Mcmanus.
View institutional ownership trends
.

How do I buy shares of Azenta?

Shares of AZTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AZTA) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners